Management
Grant Froese
CEO
Mr. Froese is a retail industry veteran with 38 years of experience at Loblaw, Canada’s largest food retailer, with his most recent position being Chief Operating Officer prior to his short-lived retirement in April 2017. Since August 2017, Froese served as the Chief Executive Officer for Marquee Health Group, a late stage applicant under the Access to Cannabis for Medical Purposes Regulation (ACMPR) where he gained valuable industry experience and insight. Mr. Froese has extensive experience in supply chain management, digital/ecommerce businesses, marketing, brand management and operations management.
Andrew Kain
COO
Andrew Kain is a lawyer by profession with almost 25 years of extensive corporate, financial and legal experience. For 15 years, he was General Counsel to a US$5+ billion global hedge fund that operated a proprietary quantitative trading platform and managed a US$2+ billion fund of funds portfolio, where he worked with investment banks, brokerage houses, exchanges and regulatory bodies in capital markets around the globe. Most recently Andrew was in private practice providing general corporate, financial and advisory services to start-up and early stage companies in emerging industries. Andrew is also a founder and President of Windular Research and Technologies Inc., a privately held corporation that provides innovative renewable energy systems, consulting and advisory services to the global telecommunications industry.
Lisa Dea
CFO
Ms. Dea has over 20 years of experience in the finance, securities and accounting fields. Ms. Dea has been the CFO of several TSX and TSX-V listed companies where she was responsible for corporate strategy, all aspects of finance and legal, debt and capital market activities, internal and external public reporting, financial controls, processes and corporate governance. She has been instrumental in helping several companies grow from the development stage to large-scale commercial operations. Prior to her time in industry, Lisa spent eleven years at Deloitte & Touche LLP, achieving the position of Senior Manager. Ms. Dea obtained her Chartered Accountants designation in 1997 and also holds a B.Comm from the University of British Columbia.
Nick Maltchev
CTO
Mr. Maltchev is a global executive with a passion for results and building great teams. He brings a mix of strategic thinking and deep technical knowledge and over 25 years of technology experience. He has been involved with the industry since 2004 and was an integral part of the Advanced Nutrients management team over a period of 12 years, holding several positions including information technology manager, COO and general manager. Mr. Maltchev holds a BBA degree, as well as other designations in project management, cybersecurity and computer science. He is also currently in the process of finishing an MBA in management information systems.
Jonathan Hartshorn
CEO of Satipharm
Jonathan holds a degree in Pharmacology and Physiology and is a Fellow of the Institute of Chartered Accountants. He has over 15 years experience in the Life Sciences arena, including Discovery, Development, Clinical Trials and OTC/ Grocery retail experience, as well as transaction experience including M&A and financings. He has held key leadership positions in Pfizer Consumer Healthcare Ireland, McNeil Healthcare and Venn Life Sciences Plc.
Directors
Grant Froese
CEO/Director
Mr. Froese is a retail industry veteran with 38 years of experience at Loblaw, Canada’s largest food retailer, with his most recent position being Chief Operating Officer prior to his short-lived retirement in April 2017. Since August 2017, Froese served as the Chief Executive Officer for Marquee Health Group, a late stage applicant under the Access to Cannabis for Medical Purposes Regulation (ACMPR) where he gained valuable industry experience and insight. Mr. Froese has extensive experience in supply chain management, digital/ecommerce businesses, marketing, brand management and operations management.
Peter Wall
Chairman
Peter Wall is a corporate lawyer based in Perth, Western Australia and is a Partner at one of Australia’s leading corporate and commercial law firms. He was a founding director and shareholder in Phytotech Medical Limited, the first medical cannabis company to list on the Australian Securities Exchange, which subsequently was renamed “MMJ Phytotech Ltd” after a merger with MMJ Biosciences Inc.